[1] Donald PR, Maher D, Qazi S. A research agenda to promote the management of childhood tuberculosis within national tuberculosis programmes Int J Tuberc Lung Dis 11(4):370–380, 2007.
[2] Starke JR. Childhood tuberculosis: ending the neglect. Int J Tuberc Lung Dis 6(5):373–374, 2002.
[3] Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 8(5):636–647, 2004.
[4] Harries AD et al. Childhood tuberculosis in Malawi: nationwide case-finding and treatment outcomes. Int J Tuberc Lung Dis 6(5):424–431, 2002.
[5] Jeena PM, Pillay P, Pillay T, Coovadia HM. Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa. Int J Tuberc Lung Dis 6: 672 – 678, 2002.
[6] Mukadi YD et al. Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Côte d’Ivoire. AIDS 11:1151–1158, 1997.
[7] Palme IB et al. Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis. Pediatr Infect Dis J 21: 1053–1061, 2002.
[8] Lienhardt C et al. Risk Factors for Tuberculosis Infection in Children in Contact With Infectious Tuberculosis Cases in The Gambia, West Africa. Pediatrics;111:e608 –e614, 2003.
[9] Nelson LJ, Wells CD. Op cit.
[10] Mukadi YD et al. Op Cit.
[11] van Rie A et al. Childhood tuberculosis in a urban population in South Africa: burden and risk factors. Arch Dis Child 80: 433–437, 1999.
[12] Qazi S, Khan S, Khan M A. Epidemiology of childhood tuberculosis in a hospital setting. J Pak Med Assoc 48: 90–93, 1998.
[13] Singh M et al. Prevalence and risk factors for transmission of infection among children in household contact with adults having pulmonary tuberculosis. Arch Dis Child;90:624–628, 2005.
[14] Lienhardt C et al. Op cit.
[15] Beyers N et al. A prospective evaluation of children under the age of 5 years living in the same household as adults with recently diagnosed pulmonary tuberculosis. Int J Tuberc Lung Dis. 1:38–43, 1997.
[16] Marais BJ et al. The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis (3):278–285, 2004.
[17] Behr MA et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet. 353(9151):444-9, 1999.
[18] Lienhardt C et al. Op cit.
[19] Schaaf HS et al. Culture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases. BMC Infectious Diseases 7:140, 2007.
[20] Guwatudde D. Tuberculosis in Household Contacts of Infectious Cases in Kampala, Uganda. Am J Epidemiol;158:887–898, 2003.
[21] van Wyk SS et al. What is the definition of household when used for tuberculosis contact investigation in highly endemic settings. 39th IUATLD World Conference on Lung Health, abstract PC-82440-20, Paris, 2008.
[22] Heyns L et al. Nosocomial transmission of Mycobacterium tuberculosis in kangaroo mother care units: A risk in tuberculosis-endemic areas. Acta Paediatr.;95(5):535-9, 2006.
[23] Marais BJ et al. Op Cit.
[24] Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361 1168–73.
[25] Moore DP et al. Report on a tuberculosis outbreak investigation in a children’s home in Khayelitsha, Cape Town, South Africa. South African TB Conference, Durban, 2008.
[26] Lawn SD et al. Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. BMC Infect Dis; 7:99, 2007.
[27] Rangaka MX, Wilkinson KA, Seldon R, et al. Effect of HIV-1 infection on T-Cell–based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med; 175:514–20, 2007.
[28] Cotton MF et al. HIV and childhood tuberculosis: the way forward. Int J Tuberc Lung Dis 8(5):675–682, 2004.
[29] Miller F J W, Seale R M E, Taylor M D. Tuberculosis in children. Boston, MA: Little Brown, 1963.
[30] Marais BJ et al. Am J Respir Crit Care Med, 2006, op cit.
[31] Corbett EL et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med; 163: 1009–1021, 2003
[32] Jereb J A, Kelly G D, Porterfield D S. The epidemiology of tuberculosis in children. Sem Pediatr Infect Dis 4: 220–231, 1993.
[33] Harries AD et al. Op cit.
[34] Wells CD, Nelson LJ. New international efforts in childhood tuberculosis: proceedings from the 2002 Workshop on Childhood Tuberculosis, Montreal, Canada, 6–7 October 2002. Int J Tuberc Lung Dis 8(5):630–635, 2004.
[35] Beyers N et al. The use of a geographical information system (GIS) to evaluate the distribution of tuberculosis in a high-incidence community. S Afr Med J. 1996 Jan;86(1):40-1, 44.
[36] Donald PR. Childhood tuberculosis: out of control? Current Opinion in Pulmonary Medicine, 8:178–182, 2002.
[37] Kiwanaku J, Graham SM, Coulter JBS, et al.: Diagnosis of pulmonary tuberculosis in children in an HIV-endemic area, Malawi. Ann Trop Paediatr, 21:5–14, 2001.
[38] Egwaga SM et al. The impact of the HIV epidemic on tuberculosis transmission in Tanzania. AIDS; 20:915–21, 2006.
[39] Migliori GB et al. Risk of infection andestimated incidence of tuberculosis in northern Uganda. Eur Respir J, 7:946–53, 1994.
[40] Odhiambo JA et al. Tuberculosis and the HIV epidemic: increasing annual risk of tuberculous infection in Kenya, 1986–1996. Am J Public Health 1999; 89:1078–82.
[41] Middelkoop K et al. Rates of Tuberculosis Transmission to Children and Adolescents in a Community with a High Prevalence of HIV Infection among Adults. Clinical Infectious Diseases 47:349–55, 2008.
[42] Rieder HL. On the Risk of Being and Becoming Infected with Mycobacterium tuberculosis. Clinical Infectious Diseases 47:356–7, 2008.
[43] Mukadi Y B, De Cock K. Special challenges of tuberculosis in HIV-infected children. Annales Nestlé 55: 34–41, 1997.
[44] Cotton MF et al. Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Int J Tuberc Lung Dis 12(2):225–227, 2008.
[45] Zar H J et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. BMJ 334: 136, 2007.
[46] Martinson N et al. Incidence of Tuberculosis in HIV-infected Children: The Influence of HAART. 13th CROI, Denver, Abstract 22, 2006.
[47] Marais BJ et al. The burden of childhood tuberculosis and the accuracy of community-based surveillance data. Int J Tuberc Lung Dis. 10(3):259-63, 2006.
[48] Moore DP, Madhi SA. Defining the burden of tuberculosis in a cohort of children enrolled in a pneumococcal vaccine trial. The South African TB Conference, Durban, 2008.
[49] Kouakoussui A et al. Respiratory manifestations in HIV-infected children pre- and post-HAART in Abidjan, the Ivory Coast. Paediatr Respir Rev. 2004 Dec;5(4):311-5.
[50] Chintu C, Mudenda V, Lucas S, et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet 360: 985–90, 2002.
[51] Elenga N et al. Diagnosed Tuberculosis During the Follow-up of a Cohort of Human Immunodeficiency Virus-Infected Children in Abidjan, Coˆte d’Ivoire. ANRS 1278 Study. The Pediatric Infectious Disease Journal, 24: 1077–1082, 2005.
[52] Marais BJ et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. INT J TUBERC LUNG DIS 8(4):392-402, 2004.